Actavis launches generic olanzapine in four European countries
This article was originally published in Scrip
Executive Summary
Actavis launched generic olanzapine (Lilly's treatment of schizophrenia and bipolar disorder Zyprexa) in Bulgaria, Hungary, Slovakia and Spain immediately after Lilly's patents expired in these countries on 24 April. It may launch Olanzapine Actavis also in other European countries in September when the patents expire there.